Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Nov;78(2):207–213.

Characterization of hepatitis B surface antigen (HBsAg) induced interleukin-2 secretion in chronic asymptomatic carriers of HBsAg.

S P Sylvan 1, U B Hekkström 1
PMCID: PMC1534656  PMID: 12412750

Abstract

Peripheral T lymphocytes from asymptomatic HBsAg carriers and hepatitis B (HB) immune (naturally acquired or vaccine induced) donors were induced into interleukin-2 (IL-2) secretion by plasma-derived HBsAg and the translational products of the S- and pre-S2+S gene of HB virus (HBV) in vitro. Biphasic time courses of IL-2 secretion were obtained for all donors tested. The first peak seemed to be mitogenically induced, as it was demonstrated in T cell cultures from asymptomatic HBsAg carrier, HB-immune donors as well as HB-susceptible controls and exhibited similar kinetics to that of the mitogen phytohaemagglutinin (PHA) induced IL-2 secretion. The mitogenically induced IL-2 secretion was prompt in T cell cultures from asymptomatic HBsAg carriers compared with HB-immune and HB-susceptible donors, and significantly higher after stimulation with high (100-1,000 ng/ml) compared with low (0.1-1.0 ng/ml) concentrations of HBsAg, indicating that T lymphocytes from asymptomatic HBsAg carriers are mitogenically pre-activated by circulatory HBsAg in high concentrations in vivo. In contrast, the second peak obtained after 4-7 days of antigen stimulation was antigen-specifically induced as it was not registered in control culture supernatants from HB-susceptible individuals. T cells from six out of seven asymptomatic HBsAg carriers exhibited reduced responsiveness to the translational product of the S-gene of HBV, whereas T cells from HB-immune donors responded equally well to pre-S2 containing and non-containing HBsAg preparations. An HBsAg-induced mitogenic T cell activation and aberrant T cell sensitization towards S-gene-encoded determinants may result in altered immunoregulatory functions within the T cell compartment, with consequences for the development of an adequate antibody response to HBsAg in asymptomatic HBsAg carriers.

Full text

PDF
207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong R. B., Butchko G. M., Kiley S. C., Phelan M. A., Ennis F. A. Mitogenicity of influenza hemagglutinin glycoproteins and influenza viruses bearing H2-hemagglutinin. Infect Immun. 1981 Oct;34(1):140–143. doi: 10.1128/iai.34.1.140-143.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnaba V., Levrero M., Ruberti G., van Dyke A., Perrone A., Musca A., Balsano F. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients. Clin Exp Immunol. 1987 Nov;70(2):283–288. [PMC free article] [PubMed] [Google Scholar]
  3. Brechot C., Hadchouel M., Scotto J., Degos F., Charnay P., Trepo C., Tiollais P. Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet. 1981 Oct 10;2(8250):765–768. doi: 10.1016/s0140-6736(81)90182-3. [DOI] [PubMed] [Google Scholar]
  4. Celis E., Miller R. W., Chang T. W. Antigen-induced production of lymphokines by human T cell clones specific for hepatitis B surface antigen. Hum Immunol. 1984 Dec;11(4):229–237. doi: 10.1016/0198-8859(84)90062-4. [DOI] [PubMed] [Google Scholar]
  5. Dohlsten M., Hedlund G., Sjögren H. O., Carlsson R. Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies. Eur J Immunol. 1988 Aug;18(8):1173–1178. doi: 10.1002/eji.1830180805. [DOI] [PubMed] [Google Scholar]
  6. Einarsson M., Kaplan L., Utter G. Purification of hepatitis B surface antigen by affinity chromatography. Vox Sang. 1978;35(4):224–233. doi: 10.1111/j.1423-0410.1978.tb02926.x. [DOI] [PubMed] [Google Scholar]
  7. Fauci A. S. Human B lymphocyte function: cell triggering and immunoregulation. J Infect Dis. 1982 May;145(5):602–612. doi: 10.1093/infdis/145.2.602. [DOI] [PubMed] [Google Scholar]
  8. Fletcher M., Goldstein A. L. Recent advances in the understanding of the biochemistry and clinical pharmacology of interleukin-2. Lymphokine Res. 1987 Winter;6(1):45–57. [PubMed] [Google Scholar]
  9. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  10. Grabstein K., Dower S., Gillis S., Urdal D., Larsen A. Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes. J Immunol. 1986 Jun 15;136(12):4503–4508. [PubMed] [Google Scholar]
  11. Hellström U., Sylvan S., Lundbergh P. Regulatory functions of T- and accessory-cells for hepatitis B surface antigen induced specific antibody production and proliferation of human peripheral blood lymphocytes, in vitro. J Clin Lab Immunol. 1985 Apr;16(4):173–181. [PubMed] [Google Scholar]
  12. Kam W., Rall L. B., Smuckler E. A., Schmid R., Rutter W. J. Hepatitis B viral DNA in liver and serum of asymptomatic carriers. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7522–7526. doi: 10.1073/pnas.79.23.7522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kratz S. S., Kurlander R. J. Characterization of the pattern of inflammatory cell influx and cytokine production during the murine host response to Listeria monocytogenes. J Immunol. 1988 Jul 15;141(2):598–606. [PubMed] [Google Scholar]
  14. Lipkowitz S., Greene W. C., Rubin A. L., Novogrodsky A., Stenzel K. H. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J Immunol. 1984 Jan;132(1):31–37. [PubMed] [Google Scholar]
  15. Milich D. R., Louie R. E., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions. J Immunol. 1985 Jun;134(6):4194–4202. [PubMed] [Google Scholar]
  16. Morimoto C., Letvin N. L., Boyd A. W., Hagan M., Brown H. M., Kornacki M. M., Schlossman S. F. The isolation and characterization of the human helper inducer T cell subset. J Immunol. 1985 Jun;134(6):3762–3769. [PubMed] [Google Scholar]
  17. Nielsen J. O., Nielsen M. H., Elling P. Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers. N Engl J Med. 1973 Mar 8;288(10):484–487. doi: 10.1056/NEJM197303082881002. [DOI] [PubMed] [Google Scholar]
  18. Oh-Ishi T., Goldman C. K., Misiti J., Waldmann T. A. Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6478–6482. doi: 10.1073/pnas.85.17.6478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Palacios R. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2. J Immunol. 1984 Apr;132(4):1833–1836. [PubMed] [Google Scholar]
  20. Paliard X., de Waal Malefijt R., Yssel H., Blanchard D., Chrétien I., Abrams J., de Vries J., Spits H. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol. 1988 Aug 1;141(3):849–855. [PubMed] [Google Scholar]
  21. Reinicke V., Dybkjaer E., Poulsen H., Banke O., Lylloff K., Nordenfelt E. A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology. N Engl J Med. 1972 Apr 20;286(16):867–870. doi: 10.1056/NEJM197204202861604. [DOI] [PubMed] [Google Scholar]
  22. Saxena S., Nouri-Aria K. T., Anderson M. G., Williams R., Eddleston A. L. In vitro alpha-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease. J Hepatol. 1985;1(4):385–393. doi: 10.1016/s0168-8278(85)80776-5. [DOI] [PubMed] [Google Scholar]
  23. Smith K. A., Lachman L. B., Oppenheim J. J., Favata M. F. The functional relationship of the interleukins. J Exp Med. 1980 Jun 1;151(6):1551–1556. doi: 10.1084/jem.151.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Spitz M., Gearing A., Callus M., Spitz L., Thorpe R. Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes. Immunology. 1985 Mar;54(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  25. Sylvan S. P., Hellström U. B., Lundbergh P. R. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers. Clin Exp Immunol. 1985 Nov;62(2):288–295. [PMC free article] [PubMed] [Google Scholar]
  26. Vento S., Chen S. H., Giuliani-Piccari G., O'Brien C. J., Dal Monte P. R., Eddleston A. L., Howard C. R., Williams R. Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus. Immunology. 1987 Dec;62(4):593–598. [PMC free article] [PubMed] [Google Scholar]
  27. Yamauchi K., Nakanishi T., Chiou S. S., Obata H. Suppression of hepatitis B antibody synthesis by factor made by T cells from chronic hepatitis B carriers. Lancet. 1988 Feb 13;1(8581):324–326. doi: 10.1016/s0140-6736(88)91119-1. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES